Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Five GLP-1 products will collectively bring in $470 billion by 2030, and the market leaders are working to hold back ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

like Prozac for depression in 1987. Concerned that Lilly was perhaps getting too complacent from its past success, in his first speech as CEO to 150 company executives, he emphasized three things ...

James R. Hagerty, known as Bob, is based in Pittsburgh and writes obituaries and other feature stories for The Wall Street ...

The business strategies of companies involved in chiral drug development were cast into doubt in October after Eli Lilly (Indianapolis, IL) decided not to pursue the development of R-fluoxetine ...